Feature | P value* Rise in serum creatinine (N=35) | P value* Rise in R-SLEDAI (N=90) |
Institution | 0.0388 | 0.1178 |
Race | 0.0154 | 0.0800 |
Age | 0.8346 | 0.9765 |
Male gender | <0.0001 | 0.6360 |
LN class | 0.0002 | 0.7791 |
Anti-RNP | 0.6489 | 0.2299 |
Anti-phospholipid | 0.0035 | 0.7202 |
Anti-Sm | 0.2519 | 0.2785 |
Anti-dsDNA | 0.3158 | 0.3118 |
Urine casts | 0.0147 | XX |
Haematuria | 0.0015 | XX |
Pyuria | 0.2360 | XX |
Proteinuria | <0.0001 | XX |
R-SLEDAI score | <0.0001 | XX |
Baseline serum creatinine | 0.2720 | 0.0001 |
Oral methotrexate† | <0.0001 | 0.3138 |
Azathioprine | 0.6454 | 0.0009 |
Mycophenolate mofetil† | 0.0003 | 0.2364 |
Rituximab† | <0.0001 | 0.7128 |
Systemic steroids† | 0.0002 | 0.5716 |
Significant values are bolded.
*Χ2 (categorical) or Welch-Satterthwaite t-test (continuous). XX indicates that the variable is part of the R-SLEDAI.
†Medications are listed when the p value is significant.
LN, lupus nephritis; R-SLEDAI, renal Systemic Lupus Erythematosus Disease Activity Index.